Troels Jordansen Appointed As Chief Executive Officer of Yaqrit, Replacing Professor Rajiv Jalan
01/10/25, 8:15 PM
Location
londonIndustry
therapeutics
biotechnology
health care
Position
chief executive officer
Yaqrit, a late-stage biotech and medtech company, announced the appointment of Troels Jordansen as its new Chief Executive Officer. Mr. Jordansen replaces Professor Rajiv Jalan, the company’s Founder and Interim CEO, and is poised to lead the company in several late-stage trials of its products for the treatment of complications associated with advanced liver disease, and to launch a phase 3 study.
Company Info
Location
london, england, united kingdom
Additional Info
Yaqrit is a clinical-stage company discovering and developing innovative treatments for patients with advanced liver disease at high risk of hospitalization and death. Yaqrit’s pipeline includes novel therapeutics in phase 2 / 3 clinical trials and two medical devices entering registrational trials providing acute and chronic treatments for advanced cirrhosis and acute-on-chronic liver failure, where there is an urgent need for more effective treatments.